Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ichnos Sciences, Inc.

https://www.ichnossciences.com/

Latest From Ichnos Sciences, Inc.

Lupin Seeks Partners For Biosimilars And Oncology Research

Buoyed by a $50m milestone payment for a MEK inhibitor licensed to Boehringer Ingelheim and in a bid to mitigate the burn on profits, Lupin is considering partnerships for biosimilars, specialty products and other NCEs with recently spun-off oncology assets being first in line for a deal. But FY22 earnings guidance has been lowered.

Commercial Biosimilars

Lupin Seeks Partners For Biosimilars, Oncology Research

Buoyed by a $50m milestone payment for a MEK inhibitor licensed to Boehringer Ingelheim and in a bid to mitigate the burn on profits, Lupin is considering partnerships for biosimilars, specialty products and other NCEs with recently spun-off oncology assets being first in line for a deal. But FY22 earnings guidance has been lowered.

Commercial Sales & Earnings

Crunch Time For Glenmark’s US Innovation Arm, Founding CEO To Exit

Glenmark’s spin-out innovation arm, Ichnos, faces a crucial year of effort to partner out certain potential first-in-class therapeutics for autoimmune diseases and also to advance its oncology pipeline. Meanwhile, CEO and ex-Gilead executive Alessandro Riva is moving on.

Commercial Deals

Amgen/KK’s Atopic Dermatitis Deal Shows OX40’s Allure, But Market Still Tough

Amgen said Phase II data are planned for the EADV 2021 meeting, but KHK4083 will need a strong showing.

See All

Company Information

  • Industry
  • Biotechnology
  • Other Names / Subsidiaries
    • Glenmark Pharmaceuticals Limited
    • Ichnos
UsernamePublicRestriction

Register